dokumeds

What dokumeds does

Dokumeds is a European contract research organization (CRO) founded in 1995 and headquartered in Riga, Latvia, that provides full-service clinical development support to pharmaceutical, biotechnology, and medical device companies, as well as academic and government organizations. The company's core offering spans the clinical development lifecycle — from investigational new drug (IND) applications through regulatory submissions — and includes clinical project management, clinical operations and monitoring, biometrics (biostatistics, statistical programming, data management), regulatory strategy, and quality assurance. Its underlying technology stack is that of a traditional professional-services CRO rather than a software platform: no proprietary AI/ML systems, APIs, SDKs, or model assets are disclosed, and the firm does not maintain a consumer-facing application. The company operated 10 offices across multiple continents prior to its acquisition, enabling multinational program delivery.

Dokumeds operated on a professional-services revenue model, quoting and contracting on a per-project basis with sponsors. Customer acquisition was sales-led and executed through direct engagement with enterprise pharma and biotech buyers, supplemented by RFP/RFI processes and industry channels. Pricing was not publicly disclosed, consistent with the bespoke, contract-based nature of full-service CRO work. The company employed a horizontal segmentation strategy, with pharmaceutical and biotechnology companies designated as primary segments and medical device, academic, and government organizations as secondary segments. No specific customer logos, contract values, or revenue figures were disclosed in the source material.

On December 8, 2021, Dokumeds was acquired by Rho, a privately held US-based global CRO headquartered in Research Triangle Park, North Carolina, with Edgemont Partners serving as Rho's exclusive financial advisor. The acquisition combined complementary therapeutic specialties and geographic footprints, integrating Dokumeds' European and multi-continent office network into Rho's broader delivery platform. Following the transaction, Dokumeds ceased operating as an independent entity. Terms of the deal and post-acquisition ownership stakes were not disclosed.

Name

dokumeds

Legal name

Dokumeds

Website

https://dokumeds.com

Company type

Private

Founded year

1995

Operating status

Acquired

Short description

Dokumeds is a European clinical research organization founded in 1995 and headquartered in Riga, Latvia, providing full-service clinical development — clinical operations, biometrics, regulatory strategy, and quality assurance — to pharmaceutical, biotechnology, medical device, and academic/government sponsors across multiple continents.

Ownership category

akta.pro rank

Product category

Clinical Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Regulatory submissions
• Drug development services

Headquarters

HQ city

Riga

HQ country

Latvia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Development Services: Full-service CRO providing clinical development services from investigational new drug applications through regulatory submissions. Services include project management, clinical operations, biometrics, regulatory strategy, and quality assurance.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Dokumeds is a full-service contract research organization (CRO) providing clinical development services to pharmaceutical, biotechnology, and medical device companies. Its offerings span the full clinical lifecycle from investigational new drug (IND) applications through regulatory submissions, covering project management, clinical operations, biometrics, regulatory strategy, and quality assurance. The company operates across multiple continents with 10 offices, delivering multinational clinical trial programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Dokumeds Clinical Research Services Full-service contract research organization (CRO) providing clinical development services from investigational new drug (IND) applications through regulatory submissions. Services include project management, clinical operations, biometrics, regulatory strategy, and quality assurance for pharmaceutical, biotechnology, and medical device companies across multiple continents.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• Rho: US-based privately held full-service CRO that acquired Dokumeds in December 2021; the closest peer because the two now operate as a combined entity offering end-to-end clinical development with complementary US/European footprints.
• Medpace: Mid-to-large full-service clinical CRO focused on therapeutically specialized Phase II–IV trials for small and mid-sized biopharma sponsors; directly comparable as a sponsor-facing clinical CRO with similar full-service orientation.
• Worldwide Clinical Trials: Mid-sized privately held global CRO providing full-service clinical development across CNS, cardiometabolic, oncology and rare diseases; directly comparable as a similarly sized full-service peer with specialty TA focus.

Broad incumbents

• ICON plc: One of the largest global full-service CROs offering clinical operations, biometrics, regulatory, and laboratory services to pharma and biotech; directly comparable as a peer in full-service clinical trial delivery.
• Parexel International: Large global full-service CRO (now private following EQT/Goldman Sachs take-private) offering clinical development, regulatory, and commercialization services; competes for the same multinational sponsor programs.
• IQVIA: The largest global CRO with the broadest full-service capabilities including clinical operations, real-world evidence, and technology platforms; the dominant incumbent peer for any full-service clinical CRO.
• Labcorp Drug Development (formerly Covance): Major global CRO integrated with central laboratory services, offering end-to-end clinical development and companion diagnostics; comparable as a large full-service competitor in clinical trial delivery.
• Charles River Laboratories: Global CRO/CDMO offering preclinical and clinical services to biopharma; overlapping clinical operations and biometrics capabilities make it a relevant broader peer.
• Syneos Health: Global full-service biopharma solutions organization offering clinical development and commercialization services; comparable as a large peer competing for the same outsourced clinical trial mandates.

Emerging players

• Clario: Privately held clinical trial technology and endpoint services provider (formed from Bioclinica/ERT); comparable in clinical trial data capture, eCOA, and imaging services that overlap with Dokumeds' biometrics capabilities.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/dokumeds

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about dokumeds